Talent Acquisition Partner contributing to dynamic recruitment at Excelya, impacting clinical research. Collaborating with teams to lead high - volume hiring for critical roles globally.

Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence.
Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, Pain Treatment & CNS, and Late Phase & RWE.
Browse and apply for open jobs at Excelya.
Talent Acquisition Partner contributing to dynamic recruitment at Excelya, impacting clinical research. Collaborating with teams to lead high - volume hiring for critical roles globally.
Talent Acquisition Partner managing high - volume recruitment for Excelya in clinical research. Collaborating with managers and nurturing talent pipelines in a fast - paced environment.
Clinical Vendor Manager overseeing clinical studies from start - up to close - out at Excelya, a mid - size CRO. Role involves coordination with internal stakeholders and ensuring compliance with contractual obligations.
Clinical Vendor Manager driving study start - up coordination and CRO oversight at Excelya. Supporting clinical research projects from start - up through close - out with an ambitious team in France.
Project Manager focusing on systems optimization to enhance operational efficiency at Excelya. Coordinating teams and driving innovation in clinical project management.
Quality Assurance Officer ensuring quality and compliance in clinical research operations at Excelya. Leading data integrity initiatives and working with R&D teams across prioritized processes for 2025 - 2026.